Select | Gene | Cds | Cds_length | GC_content | Pep | Pep_length |
---|---|---|---|---|---|---|
Vivi5g03025 | ATGTCGCGCCAGTCGACGGGTTCCGCTTTCACCAAATCCAAGACCCTCGACAACAAATATATGCTGGGAGATGAGATTGGGAAAGGAGCTTATGGTCGAGTTTACAAAGGTTTGGACCTGGAGAATGGAGATTTTGTTGCAATTAAGCAAGTTTCTTTGGAGAATATTGCTCAGGAAGATCTCAACATCATCATGCAAGAGATTGATTTGTTAAAGAATTTGAACCACAAAAACATTGTAAAGTATCTTGGATCTTTGAAGACAAAGAGTCACCTGCATATAGTACTTGAGTATGTGGAGAACGGCTCACTTGCAAATATTATCAAGCCAAATAAATTTGGACCCTTTCCAGAATCTTTGGTTGCAGTTTATATTGCCCAGGTGTTGGAAGGCTTGGTTTACCTACACGAACAAGGTGTTATCCATCGTGATATTAAGGGTGCAAATATATTGACAACTAAAGAGGGTCTTGTCAAACTTGCTGATTTTGGCGTTGCAACAAAATTAACAGAGGCTGATGTTAATACTCATTCCGTTGTTGGAACACCATACTGGATGGCACCAGAGGTTATAGAAATGTCTGGGGTTTGTGCAGCTTCTGACATTTGGAGTGTTGGCTGTACAGTTATTGAGCTTCTTACATGCGTGCCTCCTTATTATGATTTGCAGCCTATGCCAGCTCTTTTCCGTATTGTCCAGGATGAACACCCTCCAATTCCTGATAGTCTTTCGCCTGACATTACTGATTTTCTGCATCAATGCTTTAAGAAGGATGCTAGACAAAGACCTGATGCTAAAACGCTGTTGTCTCACCCCTGGATTCAAAACTGCAGACGTGCCCTGCAGTCTTCTCTTCGTCATAGTGGATCATTAAGAAATATAGAGGAAGATGATGCTGCAGATGGAAAAGTTTCTGGTGGTGATCGTAAGCTTGCAGGTGAAAACTCTTCTGTGGAGAAACAGGGCACTGTGGCTGCTGATAGCAGCAGATCTCAAGAGGAAAGTGCCTCAGATTCTAATTTTCCCAACGAAAGAACTGAAAAGGCAGATGATTTCTCATCTGATGAGGTTTTTACCTTAGCCATTCACGAGAAGTCCTTTCAACAAACTGGTTCTGGCAAACTCTCTCATGATGGAGAAGTGGGTAGTTCTGAGCCTACTGGTAATCATGAAATTTCAAATGCCAAAGAACTTCATGAAGTCACGATGAATGGAGAAGTTGGATCACCACAGTCAAGAGGAGTGGCTAATAAAGTTGGAGTAAAAGACAGTTCTATCAATAATGGCAAAAAATCATTTGCTTTTGGACCAAGAGGACTTGATAAAGGTCCCACAAAGGCTATGAAGATACTGCACTCTGCAGAAGGAAATGAGCTGAGCAAATTTAGTGACCCTCCGGGAGATGCCTACTTGGATGATTTATTTCCTTTAGACAAACGACATGGGGAGGTTGTAGGTGAGGCATCCACTTCTGCATCAACTTCACACATGGCAAAAGGCAATGTATCTTCGATTGACGGAGGAGAAAAAGACCTGGCCAAAGAGCTGAGGGCTACAATCGCAAGAAAGCAATGGGAGAAAGAGAGTGAAATTGGACAGGCAAACAACGGTGGGAACCTTTTACACCGAGTTATGATAGGTGTTCTAAAAGACGATGTGATTGATATAGATGGTTTGGTATTTGATGAAAAACTTCCTGGAGAGAACCTTTTTCCTCTGCAGGCCGTTGAGTTTAGCAAATTAGTTGGTTCATTAAAGCCCGAGGAATCAGAAGATGTGATTGTCTCTGCCTGTCAGAAACTCATTGGTATATTTCAGCAGCGCTCAGAGCAGAAGCTTGTTTTTGTTACCCAGCATGGTTTACTTCCTCTAACTGACTTGCTTGAAGTTCCTAAAACACGTGTCATATGTTCTGTGCTTCAGCTTATAAATCAAATAATTAAAGACAACACTGATTTTCAAGAAAATGCTTGTCTTGTTGGATTGATTCCTGCAGTCATGAGCTTTGCTGTACCTGATCGTCCCCGGGATATTCGTATGGAAGCAGCTTTTTTTTTACAGCAGCTTTGTCAGTCAAGTTCTTTGACGTTACAAATGTTTATAGCTTGCCGTGGAATACCTGTTTTGGTGGGATTTCTCGAAGCTGATTATGCCAAGTACAGGGAAATGGTTCATCTGGCTATTGATGGCATGTGGCAGGTATTTAAGCTTCAGCAGTCAACGCCTAGAAATGATTTTTGTCGGATAGCTGCAAAAAACGGCATACTCCTTAGGCTTATAAATACACTTTATAGCTTAAATGAGTCAACCCGGTTAGCATCTATGTCTGTTGGGGGAGGATTTTTAGTTGATGGTCCGATTCCACGACCACGGTCTGGTATCTTGGATCCTACTCATCCTTTTTCAATTCAGAACGAGGCACTGCTGTCTTCAGCAGATCAGCAAGATCTTTCTAAATTAAGGCGTGGAGTTCTTGATCATCACTTAGAGCCTTCACATTCTTCATCATCCAATCCTAGAAGATCAGATGCTAACTACCAAATGGATGTTGATAGACCTCAATCAAGCAATGCTGCAGCTGAAGCTGTGCCACTAGAAAAGAGTTCAAATCTTGCTTCCAGGGAATCTTCAGCAGGTACAATGAAAGAAAGAGAGAATGTCGATCGTTGGAAAAGTGATCCTTCTAGAACTGATGTTGAACTAAGACAGCAACGTCTTAGTGTTTCTGCCAACAGGACATCAACAGAAAGGCCTACAAAGTTGACAGAAGCGTCCTCAAACGGGTTATCAGTAACAGGAGCAACTCAGCAAGAGCAAGTTAGGCCTCTTCTTAGCTTGTTGGAGAAAGAGCCCCCGTCTGGACGTTTATCTGGACAGCTTGAATATGTACGTCAGTTTTCAGCGTTAGAAAGACATGAAAGTGTACTCCCTTTGTTACACGCTTCTGAGAAGAAAACAAATGGTGAACTAGACTTTTTGATGGCAGAATTCGCAGATGTTTCTCAACGTGGAAGGGAAAACGGAAATCTTGACTCCAGTGCTAGAGTGTCTCAAAGAGTTGCTCCCAAGAAATTAGGGACTTTTGGTTCTAGTGAAGGAGCTGCTTCCACATCTGGGATCGCATCTCAGACAGCATCAGGTGTATTGTCTGGTTCAGGTGTTCTAAATGCTAGACCAGGTAGTGCTACTTCATCTGGACTACTTTCCCACATGGTTTCATCATTGAATGCAGAAGTTGCAAAAGAGTACCTTGAAAAAGTGGCAGATCTTTTGCTTGAGTTTGCACAAGCGGATACAACGGTGAAGTCTTATATGTGTAGTCAAAGCTTGCTTAGTCGACTTTTCCAGATGTTTAATAGGGTAGAACCACCTATTTTGTTAAAGATACTGAAGTGTATTAATCACCTGTCAACTGATCCAAATTGCTTAGAAAATCTTCAGCGTGCTGAGGCAATCAAATACTTGATACCAAACCTTGAACTCAAAGAAGGGTCTCTTGTATCAGAGATACATCATGAAGTCCTGAATGCACTGTTCAACTTATGCAAGATAAATAAGAGGAGACAGGAACAAGCAGCTGAAAATGGAATCATTCCCCATCTAATGCAATTCATTACATCAAATTCTCCCTTGAAACAATATGCATTGCCTCTGTTGTGTGACATGGCGCATGCATCTCGTAACTCAAGGGAGCAGTTAAGGGCTCATGGTGGTTTGGATGTCTATTTAAACCTTCTTGAGGATGAGTTTTGGTCTGTGACTGCACTAGATTCAATTGCTGTTTGCTTAGCCCATGACAATGATAATAGGAAGGTTGAACAAGCATTGCTGAAGAAAGATGCAGTTCAGAAGCTGGTGATGTTCTTCCAGAGCTGTCCAGAGCAGCATTTTGTACACATATTGGAGCCGTTCTTGAAAATCATCACAAAATCTGCAAGGATCAACACCACTTTGGCTGTTAATGGATTAACGCCATTACTCATTGCTAGGCTGGATCATCAAGATGCTATAGCTCGTCTTAATTTACTCAGGCTAATAAAGGCTGTTTATGAACATCACCCTCAGCCCAAGAAACTGATTGTGGAGAACGATCTACCTGAGAAACTTCAAAACTTAATAGGGGAACGCAGAGATGGCCAAGTGTTGGTCAAACAGATGGCAACTTCATTACTTAAAGCATTACATATAAACACTGTTTTGTAA | 4203 | 0.4176 | MSRQSTGSAFTKSKTLDNKYMLGDEIGKGAYGRVYKGLDLENGDFVAIKQVSLENIAQEDLNIIMQEIDLLKNLNHKNIVKYLGSLKTKSHLHIVLEYVENGSLANIIKPNKFGPFPESLVAVYIAQVLEGLVYLHEQGVIHRDIKGANILTTKEGLVKLADFGVATKLTEADVNTHSVVGTPYWMAPEVIEMSGVCAASDIWSVGCTVIELLTCVPPYYDLQPMPALFRIVQDEHPPIPDSLSPDITDFLHQCFKKDARQRPDAKTLLSHPWIQNCRRALQSSLRHSGSLRNIEEDDAADGKVSGGDRKLAGENSSVEKQGTVAADSSRSQEESASDSNFPNERTEKADDFSSDEVFTLAIHEKSFQQTGSGKLSHDGEVGSSEPTGNHEISNAKELHEVTMNGEVGSPQSRGVANKVGVKDSSINNGKKSFAFGPRGLDKGPTKAMKILHSAEGNELSKFSDPPGDAYLDDLFPLDKRHGEVVGEASTSASTSHMAKGNVSSIDGGEKDLAKELRATIARKQWEKESEIGQANNGGNLLHRVMIGVLKDDVIDIDGLVFDEKLPGENLFPLQAVEFSKLVGSLKPEESEDVIVSACQKLIGIFQQRSEQKLVFVTQHGLLPLTDLLEVPKTRVICSVLQLINQIIKDNTDFQENACLVGLIPAVMSFAVPDRPRDIRMEAAFFLQQLCQSSSLTLQMFIACRGIPVLVGFLEADYAKYREMVHLAIDGMWQVFKLQQSTPRNDFCRIAAKNGILLRLINTLYSLNESTRLASMSVGGGFLVDGPIPRPRSGILDPTHPFSIQNEALLSSADQQDLSKLRRGVLDHHLEPSHSSSSNPRRSDANYQMDVDRPQSSNAAAEAVPLEKSSNLASRESSAGTMKERENVDRWKSDPSRTDVELRQQRLSVSANRTSTERPTKLTEASSNGLSVTGATQQEQVRPLLSLLEKEPPSGRLSGQLEYVRQFSALERHESVLPLLHASEKKTNGELDFLMAEFADVSQRGRENGNLDSSARVSQRVAPKKLGTFGSSEGAASTSGIASQTASGVLSGSGVLNARPGSATSSGLLSHMVSSLNAEVAKEYLEKVADLLLEFAQADTTVKSYMCSQSLLSRLFQMFNRVEPPILLKILKCINHLSTDPNCLENLQRAEAIKYLIPNLELKEGSLVSEIHHEVLNALFNLCKINKRRQEQAAENGIIPHLMQFITSNSPLKQYALPLLCDMAHASRNSREQLRAHGGLDVYLNLLEDEFWSVTALDSIAVCLAHDNDNRKVEQALLKKDAVQKLVMFFQSCPEQHFVHILEPFLKIITKSARINTTLAVNGLTPLLIARLDHQDAIARLNLLRLIKAVYEHHPQPKKLIVENDLPEKLQNLIGERRDGQVLVKQMATSLLKALHINTVL | 1400 |
Select | Seq ID | Length | Analysis | Description | Start | End | IPR | GO |
---|---|---|---|---|---|---|---|---|
Vivi5g03025 | 1400 | MobiDBLite | consensus disorder prediction | 828 | 937 | - | - | |
Vivi5g03025 | 1400 | PRINTS | Tyrosine kinase catalytic domain signature | 134 | 152 | IPR001245 | GO:0004672|GO:0006468 | |
Vivi5g03025 | 1400 | PRINTS | Tyrosine kinase catalytic domain signature | 96 | 109 | IPR001245 | GO:0004672|GO:0006468 | |
Vivi5g03025 | 1400 | PRINTS | Tyrosine kinase catalytic domain signature | 200 | 222 | IPR001245 | GO:0004672|GO:0006468 | |
Vivi5g03025 | 1400 | PRINTS | Tyrosine kinase catalytic domain signature | 243 | 265 | IPR001245 | GO:0004672|GO:0006468 | |
Vivi5g03025 | 1400 | FunFam | MAP3K epsilon protein kinase 1 | 572 | 786 | - | - | |
Vivi5g03025 | 1400 | MobiDBLite | consensus disorder prediction | 316 | 339 | - | - | |
Vivi5g03025 | 1400 | Gene3D | - | 570 | 785 | IPR011989 | - | |
Vivi5g03025 | 1400 | SMART | serkin_6 | 20 | 274 | IPR000719 | GO:0004672|GO:0005524|GO:0006468 | |
Vivi5g03025 | 1400 | MobiDBLite | consensus disorder prediction | 901 | 937 | - | - | |
Vivi5g03025 | 1400 | CDD | STKc_Cdc7_like | 19 | 274 | - | - | |
Vivi5g03025 | 1400 | MobiDBLite | consensus disorder prediction | 367 | 391 | - | - | |
Vivi5g03025 | 1400 | SUPERFAMILY | ARM repeat | 579 | 774 | IPR016024 | - | |
Vivi5g03025 | 1400 | PANTHER | MITOGEN-ACTIVATED KINASE KINASE KINASE | 17 | 722 | - | - | |
Vivi5g03025 | 1400 | ProSitePatterns | Serine/Threonine protein kinases active-site signature. | 140 | 152 | IPR008271 | GO:0004672|GO:0006468 | |
Vivi5g03025 | 1400 | ProSiteProfiles | Protein kinase domain profile. | 20 | 274 | IPR000719 | GO:0004672|GO:0005524|GO:0006468 | |
Vivi5g03025 | 1400 | FunFam | MAP3K epsilon protein kinase 1 | 17 | 305 | - | - | |
Vivi5g03025 | 1400 | SUPERFAMILY | ARM repeat | 1067 | 1393 | IPR016024 | - | |
Vivi5g03025 | 1400 | MobiDBLite | consensus disorder prediction | 292 | 351 | - | - | |
Vivi5g03025 | 1400 | FunFam | MAP3K epsilon protein kinase 1-like | 1054 | 1395 | - | - | |
Vivi5g03025 | 1400 | MobiDBLite | consensus disorder prediction | 878 | 900 | - | - | |
Vivi5g03025 | 1400 | Pfam | Protein kinase domain | 21 | 274 | IPR000719 | GO:0004672|GO:0005524|GO:0006468 | |
Vivi5g03025 | 1400 | SMART | arm_5 | 1185 | 1224 | IPR000225 | GO:0005515 | |
Vivi5g03025 | 1400 | SMART | arm_5 | 608 | 648 | IPR000225 | GO:0005515 | |
Vivi5g03025 | 1400 | SMART | arm_5 | 1139 | 1183 | IPR000225 | GO:0005515 | |
Vivi5g03025 | 1400 | ProSitePatterns | Protein kinases ATP-binding region signature. | 26 | 49 | IPR017441 | GO:0005524 | |
Vivi5g03025 | 1400 | MobiDBLite | consensus disorder prediction | 830 | 854 | - | - | |
Vivi5g03025 | 1400 | Gene3D | - | 1054 | 1397 | IPR011989 | - | |
Vivi5g03025 | 1400 | MobiDBLite | consensus disorder prediction | 292 | 308 | - | - | |
Vivi5g03025 | 1400 | Gene3D | Transferase(Phosphotransferase) domain 1 | 17 | 305 | - | - | |
Vivi5g03025 | 1400 | SUPERFAMILY | Protein kinase-like (PK-like) | 17 | 275 | IPR011009 | - | |
Vivi5g03025 | 1400 | MobiDBLite | consensus disorder prediction | 487 | 506 | - | - | |
Vivi5g03025 | 1400 | MobiDBLite | consensus disorder prediction | 487 | 501 | - | - |
Select | Gene | Chromosome | Start | End | Duplicated_type |
---|---|---|---|---|---|
Vivi5g03025 | Vivi-Chr5 | 118472667 | 118502297 | Dispersed/Tandem |
Select | Gene | Gene_start | Gene_end | Function | Ath_gene | Identity(%) | E-value | Score |
---|---|---|---|---|---|---|---|---|
Vivi5g03025 | 1 | 1400 | MAP Kinase Kinase Kinase | AT3G13530 | 71.649 | 0.0 | 1977 |
Select | Regulatory Factors | Family | Gene | Hmm_acc | Hmm_name | E_value | Clan |
---|---|---|---|---|---|---|---|
PK | STE_STE-Pl | Vivi5g03025 | Pkinase | 4.6e-73 | CL0016 |
Select | Query | KO | Definition | Second KO | KEGG Genes ID | GHOSTX Score |
---|---|---|---|---|---|---|
Vivi5g03025 | - | - | gmx:100813256 | 2397.47 |